Catherine Susan Stika

Grants

Grants per year 2001 2002 2004 2006 2008 2010 2024

• 1 Active
• 32 Finished

Grants per year

Search results

• Active

  ENDEAVOR TO STOP NAUSEA/VOMITING ASSOCIATED WITH PREGNANCY (E-SNAP)

  Wisner, K. L., Wisner, K. L., Avram, M. J., Avram, M. J., Kim, K. A., Stika, C. S. & Stika, C. S.

  National Institute of Child Health and Human Development

  6/13/22 → 5/31/24

  Project: Research project

  • women 100%
  • pregnancy 100%
  • nausea 100%
  • vomiting 100%
  • Mirtazapine 100%
• Finished

  Molecular Basis of Altered Drug Metabolism During Pregnancy

  Wisner, K. L., Ciolino, J. D., Grobman, W. A., Rasmussen-Torvik, L. J. & Stika, C. S.

  University of Illinois at Chicago, National Institute of Child Health and Human Development

  8/10/17 → 2/28/21

  Project: Research project

  • Drug 100%
  • Drug Metabolism 100%
  • Base 100%
  • drugs 100%
  • pregnancy 100%

• Prot# VER-0007: Comparison of Aneuploidy Risk Evaluations (CARE) Performance of the Verinata Health Prenatal Aneuploidy Test Compared to Current Fetal Aneuploidy Screening Results and Pregnancy Outcomes in an 'All-Risk' Population

  Dungan, J. S., Grobman, W. A., Shulman, L. P. & Stika, C. S.

  SynteractHCR, Inc., Verinata Health, Inc.

  6/21/12 → 6/21/15

  Project: Research project

• Prot# SQNM-RND-106: Collection of Whole Blood Specimens from Pregnant Subjects to Support Research and Development

  Dungan, J. S., Grobman, W. A., Shulman, L. P. & Stika, C. S.

  Sequenom, Inc.

  5/9/11 → 5/9/14

  Project: Research project

• Impact of Combination Oral Contraceptives, Depot Medroxyprogesterone Acetate and the Levonorgestrel Intrauterine System on Diffusion of HIV Type 1 within Cervicovaginal Mucus

  Hammond, C., Hope, T. J. & Stika, C. S.

  Society of Family Planning

  10/1/10 → 10/1/14

  Project: Research project

• Prot# 511.133: A Twenty-eight Week, Open-label, Safety, Extension Trial of Flibanserin 100 Milligrams Daily in Premenopausal and Naturally Postmenopausal Women with Hypoactive Sexual Desire in North America

  Stika, C. S., Dungan, J. S., Luthringshausen, M. M., Shulman, L. P. & Tsai, S.

  Boehringer Ingelheim Pharmaceuticals, Inc.

  7/30/10 → 7/30/13

  Project: Research project

• Prot# 511.156: A Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Trial of Flibanserin, With Up-Titration, 100 Milligrams Administered Orally Once Daily in Naturally Postmenopausal Women With Hypoactive Sexual Desire Dis

  Stika, C. S., Dungan, J. S., Luthringshausen, M. M. & Shulman, L. P.

  Boehringer Ingelheim Pharmaceuticals, Inc.

  5/20/10 → 5/20/13

  Project: Research project

• Pain Control for Intrauterine Device Insertion: A Randomized Trial of 1% Lidocaine Paracervical Block

  Kiley, J. W., Hammond, C. & Stika, C. S.

  Society of Family Planning

  4/1/10 → 6/30/11

  Project: Research project

• 'Survey of Primary Care Physicians' Perceptions of Barriers to Providing Contraception to Women on Potentially Teratogenic Medications at an Urban Academic Institution

  Stika, C. S.

  Anonymous Foundation (X)

  9/15/08 → 9/14/09

  Project: Research project

• 'Survey of Primary Care Physicians' Perceptions of Barriers to Providing Contraception to Women on Potentially Teratogenic Medications at an Urban Academic Institution

  Stika, C. S.

  Anonymous Foundation (X)

  9/15/08 → 9/14/09

  Project: Research project

• Prot# TESTW008: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Libigel For the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

  Stika, C. S., Luthringshausen, M. M., Shulman, L. P. & Streicher, L. F.

  BioSante Pharmaceuticals, Inc.

  8/25/08 → 8/5/12

  Project: Research project

• Prot# TESTW007: A Phase III, Randomized, Double-B

  Stika, C. S., Luthringshausen, M. M. & Shulman, L. P.

  BioSante Pharmaceuticals, Inc.

  8/25/08 → 8/25/11

  Project: Research project

• Prot# DR-OXY-301: A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 versus Placebo in Women with Overactive Bladder

  Shulman, L. P., Dungan, J. S., Stika, C. S. & Tsai, S.

  Duramed Pharmaceuticals, Inc.

  8/14/08 → 8/14/11

  Project: Research project

• Prot# 511.84: A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams to 100 Milligrams Daily in Women with Hypoactive Sexual Desire Disorder

  Stika, C. S., Dungan, J. S., Luthringshausen, M. M. & Shulman, L. P.

  Boehringer Ingelheim Pharmaceuticals, Inc.

  7/18/07 → 7/18/10

  Project: Research project

• Prot# MA 19547:Randomized, Open-Label, Multi-Center Study to Investigate Patient Preference on Dosing in Women w/Postmenopausal Osteoporosis Treated w/Once-Monthly Ibandronate & Once-Weekly Risedronate. A 6-Month, 2-Sequence, & 2-Period Crossov

  Shulman, L. P., Luthringshausen, M. M. & Stika, C. S.

  Quintiles, Inc., Hoffman-La Roche, Inc.

  12/18/06 → 3/18/07

  Project: Research project

• Prot# MA 19547:Randomized, Open-Label, Multi-Center Study to Investigate Patient Preference on Dosing in Women w/Postmenopausal Osteoporosis Treated w/Once-Monthly Ibandronate & Once-Weekly Risedronate. A 6-Month, 2-Sequence, & 2-Period Crossov

  Shulman, L. P., Luthringshausen, M. M. & Stika, C. S.

  Quintiles, Inc., Hoffman-La Roche, Inc.

  12/18/06 → 3/18/07

  Project: Research project

• Prot# 511.70: A 24 Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Flibanserin 25 Milligrams 2x Daily & 50 Milligrams 1x & 2x Daily in Premenopausal Women w/ Hypoactive Sexual Desire Disorder in North America.

  Stika, C. S., Luthringshausen, M. M. & Shulman, L. P.

  Boehringer Ingelheim Pharmaceuticals, Inc.

  11/13/06 → 6/23/09

  Project: Research project

• Prot# 511.70: A 24 Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Flibanserin 25 Milligrams 2x Daily & 50 Milligrams 1x & 2x Daily in Premenopausal Women w/ Hypoactive Sexual Desire Disorder in North America.

  Stika, C. S., Luthringshausen, M. M. & Shulman, L. P.

  Boehringer Ingelheim Pharmaceuticals, Inc.

  11/13/06 → 6/23/09

  Project: Research project

• Prot# DR-DSG-301: A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021

  Shulman, L. P., Hammond, C., Luthringshausen, M. M. & Stika, C. S.

  Duramed Pharmaceuticals, Inc.

  10/26/06 → 4/3/08

  Project: Research project

• Prot# DR-DSG-301: A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021

  Shulman, L. P., Hammond, C., Luthringshausen, M. M. & Stika, C. S.

  Duramed Pharmaceuticals, Inc.

  10/26/06 → 4/3/08

  Project: Research project

• Prot# DR-PSE-309: Mltctr, Opn-Lbl Study to Eval. Efficacy & Safety of Extended Cycle, Low Dose, Cmbnt'n Oral Contraceptive Regimen, DP3-Lo 84/10, Which Utilizes Ethinyl Estradiol During 7 Day Interval Bt/wn Each 84-Day Cycle of Cmbnt'n Therapy for Prevent

  Shulman, L. P., Hammond, C., Luthringshausen, M. M. & Stika, C. S.

  Barr Laboratories Inc., Duramed Pharmaceuticals, Inc.

  10/6/05 → 12/4/07

  Project: Research project

• Prot# DR-PSE-309: Mltctr, Opn-Lbl Study to Eval. Efficacy & Safety of Extended Cycle, Low Dose, Cmbnt'n Oral Contraceptive Regimen, DP3-Lo 84/10, Which Utilizes Ethinyl Estradiol During 7 Day Interval Bt/wn Each 84-Day Cycle of Cmbnt'n Therapy for Prevent

  Shulman, L. P., Hammond, C., Luthringshausen, M. M. & Stika, C. S.

  Barr Laboratories Inc., Duramed Pharmaceuticals, Inc.

  10/6/05 → 12/4/07

  Project: Research project

• Effect of Vagus Nerve Stimulation on Reproductive Endocrine System in Women with Epilepsy

  Stika, C. S.

  Northwestern Memorial Foundation

  7/1/04 → 8/31/07

  Project: Research project

• Effect of Vagus Nerve Stimulation on Reproductive Endocrine System in Women with Epilepsy

  Stika, C. S.

  Northwestern Memorial Foundation

  7/1/04 → 8/31/07

  Project: Research project

• Prot# STOP 2000: A Multi-Center Clinical Trial to Demonstrate the Safety and Effectiveness of the STOP Device in Providing Permanent Contraception

  Stika, C. S.

  Conceptus, Inc.

  3/29/04 → 1/1/11

  Project: Research project